arrow
É

Émilie Lanoy

universite paris cite
H指数:36
被引数:7,800

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cemiplimab versus historical systemic treatments for locally advanced or metastatic cutaneous squamous cell carcinomas: Results from the French study TOSCA

西米普利单抗与历史全身治疗在局部晚期或转移性皮肤鳞状细胞癌中的比较:法国TOSCA研究的结果

2026-03-050
PRE
Association between late access to care and mortality for PWH: insights from the French Hospital Database on HIV (ANRS CO4-FHDH) from 2002 to 2016

晚期就诊与PWH死亡率之间的关联:来自法国HIV医院数据库(ANRS CO4-FHDH)(2002-2016年)的见解

2025-11-080
OA
Reliability of minimally trained operator's left ventricular outflow tract velocity-time integral measurement guided by artificial intelligence: protocol for a multicentre randomised controlled trial

人工智能指导下的轻度培训操作者左心室流出道速度-时间积分测量的可靠性:一项多中心随机对照试验方案

2025-10-010
OAAI
Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-19: a longitudinal cohort and propensity score analysis
LEUKEMIA
IF13.4
2022-02-0148
OAAI
Long-Term Survival in Patients Responding to Anti-PD-1/PD-L1 Therapy and Disease Outcome upon Treatment Discontinuation
2019-02-01112
OAAI
Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease
2018-03-01235
PREAI